相关实验视频
Updated: Jun 30, 2025

09:09
Lethality Bioassay Using Artemia salina L.
Published on: October 11, 2022
10.0K
验证毒性测试方法的好处超过了其成本
Anne Gourmelon1, Philippe Hubert2, Elise Grignard2
1OECD Environment Directorate, Paris, France.
ALTEX
|March 19, 2024
概括
监管测试方法的验证资金不足且没有吸引力,阻碍了用于内分泌干扰物识别的新方法的使用. 提高验证效率需要成熟的方法,可转移性研究和成本共享.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 监管科学 监管科学
背景情况:
- 测试方法的验证对于监管安全测试至关重要,但面临资金不足和缺乏科学界的参与.
- 欧洲的大量研究资金集中在制定监管决策的新方法上,包括内分泌干扰物识别.
- 研究成果和监管采用之间存在差距,原因是开发人员实验室以外的方法相关性和可靠性的考虑不足.
研究的目的:
- 解释研究项目的成果与新测试方法的监管采用之间的差距的原因.
- 为监管科学新方法的有效和资源有效验证提出改进建议.
- 分享经验教训,并为验证非直接取代动物研究的方法提出前进路径.
主要方法:
- 基于第四届内分泌干扰物年度论坛的测试方法验证挑战的讨论.
- 对候选监管测试方法缺乏采用原因的分析.
- 建议策略,以加强监管申请的验证过程.
主要成果:
- 验证活动是必不可少的,但资金不足,对科学家来说没有吸引力.
- 由于缺乏证明的相关性和可靠性,许多候选测试方法没有被使用.
- 在监管科学中,对更有效的验证流程的需求越来越大.
结论:
- 验证需要经过良好实践和文档开发的成熟方法.
- 需要强调记录良好的可转移性研究.
- 受益人之间的成本共享模式可以支持验证工作.
相关概念视频
Data Validation
162
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
162
Toxic Reactions: Overview
972
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
972
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K

